Caribou Biosciences Inc. logo

Caribou Biosciences Inc.

CRBU | NASDAQ
Chart Builder DCF Calculator
$1.30
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.30
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Market Data

Market Cap
$128.93M
Enterprise Value
$43.28M
Beta
2.28
Average Volume
1.7M
Shares Outstanding (Diluted)
100.99M
Shares Change YoY
8.55%
Institutional Ownership
39.48%
Exchange
NASDAQ
ISIN
US1420381089

Price Performance

Price Change 1M
-22.2%
Price Change 3M
-21.7%
Price Change 6M
-30.9%
Price Change YTD
-18.2%
Price Change 1Y
-32.6%
Price Change 3Y
-74.5%
Price Change 5Y
-94.6%
1M CAGR (ann.)
-21.2%
1Y CAGR (ann.)
-27.0%
5Y CAGR (ann.)
-45.7%
All-Time CAGR
-38.7%

Valuation

PE Ratio
-1.20
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
-0.04
PS Ratio
15.10
Forward PS
10.50
PB Ratio
1.31
P/FCF Ratio
-1.35
P/Adj. FCF Ratio
-1.21
P/OCF Ratio
-1.37
EV/Sales
5.07
EV/EBIT
-0.54
EV/EBITDA
-0.42
EV/FCF
-0.45
Earnings Yield
-83.1%
FCF Yield
-74.3%
Adj. FCF Yield
-82.4%

Financial Health

Net Cash
$85.66M
Total Debt
$26.66M
Cash & Short-Term Investments
$112.31M
Total Assets
$142.77M
Current Ratio
6.49
Quick Ratio
6.49
Debt / Equity Ratio
0.27
Debt / EBITDA
-0.26
Debt / FCF
-0.28
OCF / Debt
-3.59
Interest Coverage
0.00
Altman Z-Score
-5.55
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
-129.7%
Operating Profit Margin
-1282.5%
EBITDA Margin
-1037.4%
Net Profit Margin
-1030.4%
FCF Margin
-1121.7%
Adj. FCF Margin
-1244.8%
SBC / Revenue
104.7%
SBC Impact (per share)
-11.0%

Returns

Return on Assets
-72.4%
Return on Equity
-89.1%
Return on Invested Capital
-86.3%
Return on Capital Employed
-87.7%
Return on Tangible Assets
-72.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
-15.7%
Revenue CAGR 5Y
10.2%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
10.9%
EPS CAGR 5Y
6.2%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
15.2%
FCF CAGR 5Y
-5.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
-51.5%
Revenue Growth Next 3Y
24.6%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.29
EPS Growth Est (next Q)
-3.3%
Revenue Est (next Q)
$2.18M
Revenue Growth Est (next Q)
-0.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
284.6%

Cash Flow

Operating Cash Flow
$-95.78M
Free Cash Flow
$-95.75M
Adj. Free Cash Flow
$-106.26M
FCF Per Share
-$0.95
OCF Per Share
-$0.95
OCF/S Ratio
-954.5%

Income Statement

Revenue
$8.54M
Gross Profit
$-14.51M
Operating Income
$-109.47M
EBITDA
$-103.05M
Net Income
$-103.4M
EPS (Diluted)
-$1.08
Revenue / Employee
$88K
Profit / Employee
$-1.07M
Employees
97

© 2026 bestshares.com. All rights reserved.